Literature DB >> 5061978

Receptors on immunocompetent cells. IV. Direct measurement of avidity of cell receptors and cooperative binding of multivalent ligands.

J M Davie, W E Paul.   

Abstract

The interaction of antigen with specific, cell-associated receptors was measured in thermodynamic terms. The binding of (125)I-labeled 2,4-dinitrophenyl guinea pig albumin (DNP(16)GPA-(125)I) to lymphocytes from guinea pigs immunized to DNP(16)GPA is a temperature-dependent, reversible process. Measurement of association and dissociation rates of antigen-receptor complexes permits calculation of antigen-cell binding constants. These may also be calculated by equilibrium-binding techniques. Although differences in the constants calculated in these two ways exist, a clear increase in avidity of cell receptor for antigen occurs in the course of the immune response. This change in receptor avidity provides evidence that the time-dependent change in affinity of serum antibody (maturation) indeed has a cellular basis. The magnitude of the equilibrium constant is, in part, due to binding of more than one DNP group per molecule of antigen. Thus, multivalent ligands bind more effectively to cell receptors than univalent or paucivalent ligands when measured by the number of antigen molecules bound, the dissociation rate of antigen-receptor complexes, and in the relative capacity to inhibit a standard multivalent ligand (DNP(16)GPA-(125)I) from binding.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5061978      PMCID: PMC2139127          DOI: 10.1084/jem.135.3.643

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  The kinetics of the reaction between antibody and bovine serum albumin using the Farr method.

Authors:  D W TALMAGE
Journal:  J Infect Dis       Date:  1960 Jul-Aug       Impact factor: 5.226

Review 3.  Electron microscopy of the immunoglobulins.

Authors:  N M Green
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  Specific inactivation of antigen-reactive cells with 125I-labelled antigen.

Authors:  G L Ada; P Byrt
Journal:  Nature       Date:  1969-06-28       Impact factor: 49.962

5.  Studies on the effect of the carrier molecule on antihapten antibody synthesis. II. Carrier specificity of anti-2,4-dinitrophenyl-poly-l-lysine antibodies.

Authors:  W E Paul; G W Siskind; B Benacerraf
Journal:  J Exp Med       Date:  1966-04-01       Impact factor: 14.307

6.  Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response.

Authors:  J M Davie; W E Paul
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

7.  Separation of normal and immune lymphoid cells by antigen-coated coated columns. Antigen-binding characteristics of membrane antibodies as analyzed by hapten-protein antigens.

Authors:  H Wigzell; O Mäkelä
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

8.  The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response.

Authors:  M Feldmann; A Easten
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

9.  Immunoglobulins on the surface of lymphocytes. I. Distribution and quantitation.

Authors:  E Rabellino; S Colon; H M Grey; E R Unanue
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

10.  Immunological specificity of delayed and immediate hypersensitivity reactions.

Authors:  B BENACERRAF; B B LEVINE
Journal:  J Exp Med       Date:  1962-05-01       Impact factor: 14.307

View more
  12 in total

1.  Use of the defined antigen substrate spheres system as a model for analysing possible mechanisms of inhibition-blockade of anti-tumour lymphocytotoxicity.

Authors:  N Matthews; T de Kretser; R C Nairn
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

2.  Studies on the control of antibody synthesis. 3. Changes in heterogeneity of antibody affinity during the course of the immune response.

Authors:  T P Werblin; Y T Kim; F Quagliata; G W Siskind
Journal:  Immunology       Date:  1973-03       Impact factor: 7.397

3.  The effect of immunological adjuvants on the relative affinity of anti-protein antibodies.

Authors:  R E Petty; M W Steward
Journal:  Immunology       Date:  1977-01       Impact factor: 7.397

4.  Specific cellular stimulation in the primary immune response: experimental test of a quantized model.

Authors:  R Z Dintzis; B Vogelstein; H M Dintzis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

5.  The mechanism of antigenic stimulation of primary and secondary clonal precursor cells.

Authors:  N R Klinman
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

6.  Receptors on immunocompetent cells. V. Cellular correlates of the "maturation" of the immune response.

Authors:  J M Davie; W E Paul
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

7.  Complete inhibition of the expression of an idiotype by a mechanism of B-cell dominance.

Authors:  B M Eig; S T Ju; A Nisonoff
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

8.  Hapten-specific hemolytic plaque assays usually fail to detect most of the diversity in the anti-hapten response.

Authors:  B Merchant; J K Inman
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

9.  Isolation of antigen-binding cells from unprimed mice: demonstration of antibody-forming cell precursor activity and correlation between precursor and secreted antibody avidities.

Authors:  M H Julius; L A Herzenberg
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

10.  2,4-Dinitrophenyl receptors on mouse thymus and spleen cells.

Authors:  D A Lawrence; H L Spiegelberg; W O Weigle
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.